TCON logo

TRACON Pharmaceuticals, Inc. (TCON)

Profile

Full Name

TRACON Pharmaceuticals, Inc.

Ticker

NASDAQ: TCON

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 30, 2015

Indexes

Not included

Website

https://www.traconpharma.com

Employees

17

Key Details

Price

$0.03

Market cap

$109.72K(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$12.04M

Annual EPS

-$2.20(+92.09% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.03
    TCON price is $0.03

    30-Day Relative Volume

    -
    TCON 30-day relative volume value is unknown

    Price Performance

    Price Most recent change

    -
    TCON price change on Jul 16, 2025 is unknown

    Price YTD change

    0%
    TCON price has remained unchanged since January 1st

    Price 1-year change

    -64.22%
    TCON price is down -64.22% year-on-year

    Price 3-year change

    -99.92%
    TCON price is down -99.92% over the past 3 years

    Price Range

    Price All-time high

    $4200.00
    TCON price is currently -100.00% below its historical high of $4200.00

    Price 3-year low

    $0.00
    TCON price is currently +1510.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $109.72K
    TCON market capitalization is $109.72 thousand

    Market cap 3-year change

    -99.74%
    TCON market capitalization is down -99.74% over the past 3 years

    Market cap All-time high

    $3.25B
    TCON market capitalization is currently -100.00% below its historical high of $3.25 billion

    Market cap sector rank

    -
    TCON market capitalization is unknown

    Shares Outstanding

    Shares Outstanding 1-Year Change

    0%
    TCON shares outstanding has remained unchanged year-on-year

    Shares Outstanding 3-Year Change

    +218.14%
    TCON shares outstanding is up +218.14% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -0.54
    TCON beta is -0.54

    200-day SMA

    $0.04
    TCON price is currently -19.30% below its 200-day simple moving average

    50-day SMA

    $0.03
    TCON price is currently equal to its 50-day simple moving average

    RSI

    50.00
    TCON 14-day relative strength index is 50.00

    Volume

    -
    TCON 30-day relative volume value is unknown

    ATR

    $0.00
    TCON average true range is $0.00

    10-day Historical Volatility

    0.00%
    TCON 10-day historical volatility is 0.00%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $12.04M
    TCON annual revenue is $12.04 million

    Revenue Analysts estimate

    $100.00K
    TCON annual revenue is currently >+9900.00% higher than the consensus analysts' forecast

    Revenue 1-year change

    -
    TCON annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    TCON annual revenue is unknown

    EPS

    EPS

    -$2.20
    TCON annual earnings per share is -$2.20

    EPS Analysts estimate

    -
    TCON annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    +92.09%
    TCON annual earnings per share is up +92.09% year-on-year

    EPS Sector rank

    -
    TCON annual earnings per share is unknown

    Profit

    Gross profit

    -
    TCON annual gross profit value is unknown

    Gross margin

    -
    TCON annual gross profit margin value is unknown

    Operating profit

    -$6.90M
    TCON annual operating income is -$6.90 million

    Operating margin

    -57.27%
    TCON annual operating profit margin is -57.27%

    Net income

    -$3.59M
    TCON annual net profit is -$3.59 million

    Net margin

    -29.79%
    TCON annual net profit margin is -29.79%

    Expenses

    Total expenses

    $18.94M
    TCON annual total expenses is $18.94 million

    Operating expenses

    $18.94M
    TCON annual total operating expenses is $18.94 million

    Cost of goods sold

    -
    TCON annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $6.67M
    TCON annual SGA is $6.67 million

    Depreciation and amortization

    $34.00K
    TCON annual depreciation & amortization is $34.00 thousand

    Interest expense

    $7.30M
    TCON annual interest expense is $7.30 million

    Income tax

    -
    TCON annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    $3.72M
    TCON annual earnings before interest & taxes is $3.72 million

    EBITDA

    $3.75M
    TCON annual EBITDA is $3.75 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $10.11M
    TCON annual total assets is $10.11 million

    Non current assets

    $1.01M
    TCON annual long term assets is $1.01 million

    Current assets

    $9.09M
    TCON annual total current assets is $9.09 million

    Cash and cash equivalents

    $8.56M
    TCON annual cash & cash equivalents is $8.56 million

    Accounts receivable

    -
    TCON annual accounts receivable value is unknown

    Inventory

    -
    TCON annual inventory value is unknown

    Liabilities

    Total liabilities

    $10.91M
    TCON annual total liabilities is $10.91 million

    Long term liabilities

    $732.00K
    TCON annual total long term liabilities is $732.00 thousand

    Current liabilities

    $10.18M
    TCON annual total current liabilities is $10.18 million

    Accounts payable

    $2.54M
    TCON annual accounts payable is $2.54 million

    Debt

    Total debt

    $236.00K
    TCON annual total debt is $236.00 thousand

    Total debt 1-year change

    -97.64%
    TCON annual total debt is down -97.64% year-on-year

    Long term debt

    -
    TCON annual long term debt value is unknown

    Short term debt

    $236.00K
    TCON annual short term debt is $236.00 thousand

    Equity & Capital

    Shareholders equity

    -$809.00K
    TCON annual stockholders equity is -$809.00 thousand

    Book value

    -$809.00K
    TCON annual book value is -$809.00 thousand

    Retained earnings

    -$240.50M
    TCON annual retained earnings is -$240.50 million

    Working capital

    -$1.09M
    TCON annual working capital is -$1.09 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $3.68M
    TCON annual cash flow from operations is $3.68 million

    Cash from operations 1-year change

    +114.01%
    TCON annual cash flow from operations is up +114.01% year-on-year

    Cash from investing

    $0.00
    TCON annual cash flow from investing activities is $0.00

    Cash from investing 1-year change

    +100%
    TCON annual cash flow from investing activities is up +100% year-on-year

    Cash from financing

    -$12.54M
    TCON annual cash flow from financing activities is -$12.54 million

    Cash from financing 1-year change

    -163.7%
    TCON annual cash flow from financing activities is down -163.7% year-on-year

    CAPEX

    CAPEX

    -
    TCON annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    TCON annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    $3.68M
    TCON annual free cash flow is $3.68 million

    Free cash flow 1-year change

    +114%
    TCON annual free cash flow is up +114% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    TCON annual gross profit margin value is unknown

    Operating margin

    -57.27%
    TCON annual operating profit margin is -57.27%

    Net margin

    -29.79%
    TCON annual net profit margin is -29.79%

    ROA & ROE

    ROA

    -24.26%
    TCON annual return on assets is -24.26%

    ROE

    443.51%
    TCON annual return on equity is 443.51%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    TCON price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    TCON price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -0.04
    TCON price to book ratio is -0.04

    PB ratio Sector rank

    -
    TCON price to book ratio is unknown

    PS Ratio

    PS ratio

    0.03
    TCON price to sales ratio is 0.03

    PS ratio Sector rank

    -
    TCON price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -$6.16M
    TCON enterprise value is -$6.16 million

    Enterprise value Sector rank

    -
    TCON enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -1.08
    TCON EV/EBITDA is -1.08

    EV/EBITDA Sector rank

    -
    TCON EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.89
    TCON annual current ratio is 0.89

    Quick ratio

    -
    TCON annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    TCON annual debt to equity ratio is 0.00

    Interest coverage ratio

    0.51
    TCON annual interest coverage ratio is 0.51

    Risk & Stability

    Piotroski F-Score

    -
    TCON piotroski f-score value is unknown

    Altman Z-Score

    -31.04
    TCON altman z-score is -31.04

    Analyst ratings

    Recent major analysts updates

    Jul 1, 24 HC Wainwright & Co.
    Neutral
    Apr 3, 24 HC Wainwright & Co.
    Buy
    Mar 6, 24 HC Wainwright & Co.
    Buy
    Nov 20, 23 HC Wainwright & Co.
    Buy
    Aug 21, 23 JonesTrading
    Hold
    Aug 15, 23 Baird
    Outperform
    May 11, 23 Maxim Group
    Buy
    May 11, 23 Baird
    Outperform
    Mar 9, 23 HC Wainwright & Co.
    Buy
    Feb 23, 22 Baird
    Outperform

    Institutional Ownership

    Screeners with TCON included

    No data
    • What is the ticker symbol for TRACON Pharmaceuticals, Inc.?
    • Does TRACON Pharmaceuticals, Inc. pay dividends?
    • What sector is TRACON Pharmaceuticals, Inc. in?
    • What industry is TRACON Pharmaceuticals, Inc. in?
    • What country is TRACON Pharmaceuticals, Inc. based in?
    • When did TRACON Pharmaceuticals, Inc. go public?
    • Is TRACON Pharmaceuticals, Inc. in the S&P 500?
    • Is TRACON Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is TRACON Pharmaceuticals, Inc. in the Dow Jones?
    • When was TRACON Pharmaceuticals, Inc.'s last earnings report?
    • When does TRACON Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for TRACON Pharmaceuticals, Inc.?

    The ticker symbol for TRACON Pharmaceuticals, Inc. is NASDAQ:TCON

    Does TRACON Pharmaceuticals, Inc. pay dividends?

    No, TRACON Pharmaceuticals, Inc. does not pay dividends

    What sector is TRACON Pharmaceuticals, Inc. in?

    TRACON Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is TRACON Pharmaceuticals, Inc. in?

    TRACON Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is TRACON Pharmaceuticals, Inc. based in?

    TRACON Pharmaceuticals, Inc. is headquartered in United States

    When did TRACON Pharmaceuticals, Inc. go public?

    TRACON Pharmaceuticals, Inc.'s initial public offering (IPO) was on January 30, 2015

    Is TRACON Pharmaceuticals, Inc. in the S&P 500?

    No, TRACON Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is TRACON Pharmaceuticals, Inc. in the NASDAQ 100?

    No, TRACON Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is TRACON Pharmaceuticals, Inc. in the Dow Jones?

    No, TRACON Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was TRACON Pharmaceuticals, Inc.'s last earnings report?

    TRACON Pharmaceuticals, Inc.'s most recent earnings report was on July 23, 2025

    When does TRACON Pharmaceuticals, Inc. report earnings?

    The date for TRACON Pharmaceuticals, Inc.'s next earnings report has not been announced yet
    On this page